You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CYTK Sale Disclosure
Callos Andrew · SEC Form 4 · Filed Aug 31, 2026
Sale
Calculated transaction value
$702.4K
Callos Andrew EVP, Chief Commercial Officer
CYTK
Cytokinetics Inc
CYTK
Transaction date
Aug 31, 2026
Public filing date
Aug 31, 2026
Filing lag
Filed same day
CYTK daily price context
Close on/before transaction
$70.91
Aug 31, 2026
First close after public filing
$71.4
Sep 1, 2026
30-day return after filing
-7.69%
Through Sep 30, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 10,000 shares @ $70.24
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001061983-26-000090
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$935K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Cytokinetics Inc CYTK | Exercise | Aug 31, 2026 | $232.6K |
| Cytokinetics Inc CYTK Current | Sale | Aug 31, 2026 | $702.4K |
| Cytokinetics Inc CYTK | Exercise | Aug 31, 2026 | $0 |